AKT-Dependent Phosphorylation of ADAR1p110 and ADAR2 Represents a New and Important Link Between Cell Signaling and RNA Editing.


Journal

DNA and cell biology
ISSN: 1557-7430
Titre abrégé: DNA Cell Biol
Pays: United States
ID NLM: 9004522

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 31 1 2020
medline: 20 3 2020
entrez: 31 1 2020
Statut: ppublish

Résumé

RNA editing is a process by which nascent RNA transcripts are covalently modified, thus enhancing the complexity of the transcriptome. The most common modifications are deaminations of adenosine to inosine at sites of complex RNA secondary structure, a process that is carried out by the adenosine deaminase acting on double-strand RNA (ADAR) family of RNA editases. Although much has been learned about the ADAR family members since their discovery, very little information on their post-transcriptional regulation has been reported. Similar to most proteins, the ADAR family members are post-translationally modified at multiple sites. We recently reported that members of the AKT kinase family directly phosphorylate ADAR1p110 and ADAR2 on a conserved threonine within the catalytic domain of the protein. Phosphorylation was observed to differentially inhibit the enzymatic activity of the ADAR proteins toward known RNA substrates. The direct downstream involvement of the AKT kinases in multiple major signaling pathways associated with cell survival, growth, glucose metabolism (insulin signaling), and differentiation is well established; thus, the AKT kinases represent a link between ADAR-dependent A-to-I editing and major signal transduction pathways that are necessary for cell maintenance and development.

Identifiants

pubmed: 31999481
doi: 10.1089/dna.2020.5351
doi:

Substances chimiques

RNA-Binding Proteins 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1
ADAR protein, human EC 3.5.4.37
ADARB1 protein, human EC 3.5.4.4
Adenosine Deaminase EC 3.5.4.4

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

343-348

Auteurs

Manuela Piazzi (M)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza," Consiglio Nazionale delle Ricerca (IGM-CNR) Bologna, Italy.
IRCCS, Istituto Ortopedico Rizzoli, Bologna Italy.

Alberto Bavelloni (A)

Laboratory of Experimental Oncology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.

Angela Gallo (A)

RNA Editing Laboratory, Dipartimento di Oncoematologia, IRCCS, Ospedale Pediatrica Bambino Gesù, Rome, Italy.

William L Blalock (WL)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza," Consiglio Nazionale delle Ricerca (IGM-CNR) Bologna, Italy.
IRCCS, Istituto Ortopedico Rizzoli, Bologna Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH